This topic contains a solution. Click here to go to the answer

Author Question: For which of the following patients requiring ventilatory support would you recommend against using ... (Read 27 times)

jasdeep_brar

  • Hero Member
  • *****
  • Posts: 569
For which of the following patients requiring ventilatory support would you recommend against using a heat-moisture exchanger (HME) for airway humidification?
 
  1. Patient with an expired VT less than 70 of the delivered VT
  2. Patient with a spontaneous minute ventilation of 14 L/min
  3. Patient with body temperature less than 32 C
  a. 1 and 2 only
  b. 1 and 3 only
  c. 2 and 3 only
  d. 1, 2, and 3

Question 2

A dehydrated, feverish patient suffering from acute bacterial pneumonia is being intubated in order to provide mechanical ventilatory support.
 
  Which of the following devices would you select to control humidification and airway tempera-ture for this patient?
  a. Unheated large-volume wick humidifier
  b. Heated wick humidifier with servo-control
  c. Large-reservoir, high-output heated jet nebulizer
  d. Heat-moisture exchanger



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

juicepod

  • Sr. Member
  • ****
  • Posts: 310
Answer to Question 1

ANS: D
Use of HMEs should be avoided in the care of patients with secretion problems and those with low body temperature (<32 C), high spontaneous minute ventilation (>10 L/min), or air leaks in which exhaled tidal volume is less than 70 of delivered tidal volume.

Answer to Question 2

ANS: B
We prefer an optimal humidity approach and use of a heated humidifier to deliver gas in the range of 35 to 37 C at the airway.





 

Did you know?

In 1864, the first barbiturate (barbituric acid) was synthesized.

Did you know?

Chronic necrotizing aspergillosis has a slowly progressive process that, unlike invasive aspergillosis, does not spread to other organ systems or the blood vessels. It most often affects middle-aged and elderly individuals, spreading to surrounding tissue in the lungs. The disease often does not respond to conventionally successful treatments, and requires individualized therapies in order to keep it from becoming life-threatening.

Did you know?

The newest statin drug, rosuvastatin, has been called a superstatin because it appears to reduce LDL cholesterol to a greater degree than the other approved statin drugs.

Did you know?

The first monoclonal antibodies were made exclusively from mouse cells. Some are now fully human, which means they are likely to be safer and may be more effective than older monoclonal antibodies.

Did you know?

After 5 years of being diagnosed with rheumatoid arthritis, one every three patients will no longer be able to work.

For a complete list of videos, visit our video library